Medical Design Briefs online recently featured an article written by Sandi Schaible, Senior Director of Analytical Chemistry and Regulatory Toxicology at WuXi AppTec, expert in re-writing ISO...
ISO 10993-1: The Importance of Chemical Characterization
Think recent regulatory changes to ISO 10993-1 are impacting biocompatibility programs? Think again! Our Director of Analytical Chemistry, and International Delegate for ISO 10993 part 18, Sandi...
A Regulatory Consultant's Guide to ISO 10993 Updates Webinar
With changes to ISO 10993, chemical testing is more important than ever to support a medical device’s safety for market. Medical device manufacturers can no longer rely on biocompatibility testing...
WuXi AppTec to Exhibit at DeviceTalks West, Costa Mesa, California
Visit the WuXi AppTec exhibitor booth #206 at DeviceTalks West, December 11-12, 2018, to learn how we work as a seamless extension of your team and develop a comprehensive program that will meet the...
wuxi apptec to exhibit at devicetalks boston
Visit the WuXi AppTec exhibitor booth #513 at DeviceTalks Boston, which takes place Oct. 8-10, 2018. WuXi AppTec works as a seamless extension of your team to develop a comprehensive program that...
WuXi AppTec Technical Experts at the American Association of Tissue Banks Expo, Booth #49
WuXi AppTec, a longtime member of the AATB, returns for the 42nd Annual Meeting, October 9-12, 2018.
The AATB annual meeting, held in Dallas, Texas, this year, encompasses a vast array of...
Register Now for the PDA Chapter Dinner and Biocompatibility Presentation
WuXi AppTec Associate Director of Regulatory Toxicology Vanessa Haase, PhD, will present on biocompatibility testing as part of biological evaluation and ISO 10993.
WuXi AppTec to Present Case Study: Enhancing Biocompatibility Testing via Device-Specific Chemical Analysis
Associate Director of Regulatory Toxicology, Dr. Vanessa Haase, will present the case study at the Q1 Productions Medical Device Sterilization conference on September 24, 2018.
The most recent...